Literature DB >> 17199003

How to recognize, manage, and prevent complications during atrial fibrillation ablation.

Sanjay Dixit1, Francis E Marchlinski.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 17199003     DOI： 10.1016/j.hrthm.2006.10.034

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  8 in total

1.  Measuring luminal esophageal temperature during pulmonary vein isolation of atrial fibrillation.

Authors:  Daisuke Sato; Kunihiro Teramoto; Hiroki Kitajima; Naoto Nishina; Yoshitomi Kida; Hiroki Mani; Masahiro Esato; Yeong-Hwa Chun; Toshiji Iwasaka
Journal:  World J Cardiol       Date:  2012-05-26

Review 2.  Thromboembolic risk and anticoagulation strategies in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Juan F Viles-Gonzalez; Davendra Mehta
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

Review 3.  Complications of Radiofrequency Catheter Ablation for Atrial Fibrillation.

Authors:  Timir Baman; Rakesh Latchamsetty; Hakan Oral
Journal:  J Atr Fibrillation       Date:  2011-09-30

Review 4.  Role of the new target specific oral anticoagulants in the management of anticoagulation for cardioversion and atrial fibrillation ablation.

Authors:  Marcin Kowalski; Valay Parikh
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

5.  Intrapericardial balloon placement for prevention of collateral injury during catheter ablation of the left atrium in a porcine model.

Authors:  Shiro Nakahara; Rafael J Ramirez; Eric Buch; Yoav Michowitz; Marmar Vaseghi; Carlos de Diego; Noel G Boyle; Aman Mahajan; Kalyanam Shivkumar
Journal:  Heart Rhythm       Date:  2009-09-17       Impact factor: 6.343

6.  The Rate Of Complications Associated With Concomitant Use Of Dabigatran With Cryoballoon Ablation For Atrial Fibrillation.

Authors:  Valay Parikh; Vratika Agarwal; Jharendra Rijal; Vinod Chainani; Soad Bekheit; Marcin Kowalski
Journal:  J Atr Fibrillation       Date:  2014-06-30

7.  Usefulness of dabigatran etexilate as periprocedural anticoagulation therapy for atrial fibrillation ablation.

Authors:  Hirosuke Yamaji; Takashi Murakami; Kazuyoshi Hina; Shunichi Higashiya; Hiroshi Kawamura; Masaaki Murakami; Shigeshi Kamikawa; Satoshi Hirohata; Shozo Kusachi
Journal:  Clin Drug Investig       Date:  2013-06       Impact factor: 2.859

8.  Atrial Fibrillation Ablation without Interruption of Anticoagulation.

Authors:  Pasquale Santangeli; Luigi Di Biase; Javier E Sanchez; Rodney Horton; Andrea Natale
Journal:  Cardiol Res Pract       Date:  2011-04-26       Impact factor: 1.866
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.